Please Wait
Applying Filters...
menu
    • menu
    FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

    Stock Recap
    #PipelineProspector

    Menu

    Citalopram Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 50Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    29/01/2026 Matrix Pharmaceutical Inc
    U.S.A
    		 MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN CEP 2010-007 - Rev 05 Citalopram hydrochloride 2025-09-25 Valid Chemical 2203
    29/01/2026 Matrix Pharmaceutical Inc
    U.S.A
    		 MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN CEP 2019-233 - Rev 03 Citalopram hydrochloride, Process II 2025-09-29 Valid Chemical 2203
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.